|

Goserelin Clinical Trials

10 actively recruiting trials across 4 locations

Also known as: GnRH agonist, Goserelin acetate, ICI-118630, Zoladex

Pipeline

Phase 2: 8Phase 3: 2

Top Sponsors

  • Fudan University2
  • Washington University School of Medicine1
  • University of Michigan Rogel Cancer Center1
  • University of Chicago1
  • Novartis Pharmaceuticals1

Indications

  • Cancer10
  • Breast Cancer8
  • HER2-negative Breast Cancer3
  • Hormone Receptor Positive Tumor2
  • Breast Neoplasms2

Other4 trials

Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+ Breast Cancer Before and After Surgery
Phase 2
Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy
Phase 2
Immunotherapy, Hormone Therapy, and AKT Inhibitor for Premenopausal ER Positive MBC
Phase 2
SNF Platform Study of HR+/ HER2-advanced Breast Cancer
Phase 2

Birmingham, Alabama2 trials

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

Central Alabama Research

Phase 3
Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial

University of Alabama at Birmingham Cancer Center

Phase 3

Phoenix, Arizona2 trials

(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer

Mayo Clinic Arizona

Phase 2
Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial

Mayo Clinic in Arizona

Phase 2

Ann Arbor, Michigan1 trial

Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS Trial

University of Michigan Comprehensive Cancer Center

Phase 2

St Louis, Missouri1 trial

Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score

Washington University School of Medicine

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.